Company Profiles

driven by the PitchBook Platform

Avantra Biosciences

Description

Developer of protein biomarker analysis systems for research, pre-clinical and clinical diagnostic applications in the life sciences industry. The company's products include Biomarker Workstation, a multiplex immunoassay system for disease biomarker testing applications; and PATH, which are protein microarray ultra-thin nitrocellulose slides for building quantitative, multiplexed, and single capture immunoassays.

2003

Founded

PRIVATE

Status

Series A

Latest Deal Type

$7M

Latest Deal Amount

$15.1M

Total Amount Raised

2

Investors

Description

Developer of protein biomarker analysis systems for research, pre-clinical and clinical diagnostic applications in the life sciences industry. The company's products include Biomarker Workstation, a multiplex immunoassay system for disease biomarker testing applications; and PATH, which are protein microarray ultra-thin nitrocellulose slides for building quantitative, multiplexed, and single capture immunoassays.

Website:

www.avantrabio.com

Formerly Known As

Decision Biomarkers, Clinical Microarrays

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Diagnostic Equipment

Other Industries

Biotechnology

Primary Office

12 Gill Street Suite 3700 Woburn, MA 01801United States +1 (877) 395-7608
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Avantra Biosciences's full profile, request a free trial.

    Avantra Biosciences Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Avantra Biosciences Investors (2)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Courtagen CapitalVenture CapitalMajority000 0000000 0000
    Individual InvestorAngel (individual)Minority000 0000000 0000
    Courtagen Capital Venture Capital
    Individual Investor Angel (individual)
    Request full access to PitchBook